Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: PROGENICS PHARMACEUTICALS INC
Awarding agency: Department of Defense / Department of the Navy
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-03-03 to 2022-03-07
Current total value of award: $42162.84
Description: QTY (12) OF PYLARIFY (PIFLUFOLASTAT F-18) INJECTION